In other words, the associations between high BRCA1 expression and aggressive tumor behavior (poor DMFS) were consistently revealed within the tamoxifen-treated patients and within each of two other datasets of patients who did not receive tamoxifen treatment. This evidence concerns the gene BRCA1 and neoplasm.